The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Eur J Surg Oncol
; 41(8): 1097-105, 2015 Aug.
Article
in En
| MEDLINE
| ID: mdl-26026742
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Peritoneal Neoplasms
/
Pseudomyxoma Peritonei
/
Biomarkers, Tumor
/
Risk Assessment
/
Cytoreduction Surgical Procedures
/
Hyperthermia, Induced
/
Antineoplastic Agents
Type of study:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Eur J Surg Oncol
Journal subject:
NEOPLASIAS
Year:
2015
Document type:
Article
Affiliation country:
Country of publication: